Nuvalent, Inc.
NASDAQ:NUVL
84.22 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 113.243 | 63.731 | 35.559 | 15.403 | 9.746 |
General & Administrative Expenses
| 36.249 | 22.377 | 10.258 | 1.502 | 0.612 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 |
SG&A
| 36.249 | 22.377 | 10.258 | 1.502 | 0.612 |
Other Expenses
| 0 | 4.254 | -0.521 | 2.349 | -1.451 |
Operating Expenses
| 149.492 | 86.108 | 45.817 | 16.905 | 10.358 |
Operating Income
| -149.492 | -86.108 | -45.817 | -16.905 | -10.358 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 23.273 | 4.254 | -0.521 | 2.349 | -1.451 |
Income Before Tax
| -126.219 | -81.854 | -46.338 | -14.556 | -11.809 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0 | -8.508 | -0.237 | -0.017 | -0.01 |
Net Income
| -126.219 | -73.346 | -46.338 | -14.556 | -11.809 |
Net Income Ratio
| 0 | 0 | 0 | 0 | 0 |
EPS
| -2.17 | -1.48 | -0.96 | -0.3 | -0.24 |
EPS Diluted
| -2.17 | -1.48 | -0.96 | -0.3 | -0.24 |
EBITDA
| -149.492 | -86.108 | -45.817 | 2.349 | -1.451 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 |